RAS G12D-mutated NSCLC
1 clinical trials · Condition
◉ Watch RAS G12D-mutated NSCLC
| Record | Firm | Date |
|---|---|---|
| Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC (NCT06162221) | Revolution Medicines, Inc. | 2024-01-18 |
Track RAS G12D-mutated NSCLC automatically
Every clearance here is in the API, with alerts when new ones post.